Wegovy: The Weight Loss Drug with Significant Heart Benefits

A large international study has found that the weight-loss drug Wegovy reduced the risk of serious heart problems by 20% in individuals with heart disease but without diabetes. The study is the first to demonstrate that an obesity medication can not only help with weight loss but also safely prevent heart attacks, strokes, and heart-related deaths. The findings could change treatment guidelines and put pressure on health insurers to cover these medications, shifting the perception that they are solely cosmetic treatments. Wegovy is a high-dose version of the diabetes treatment Ozempic and has already been shown to reduce heart risks in people with diabetes.